Top Markets
#1 MowCat MowCat +367.92%
#2 龙虾 (Lobster) 龙虾 (Lobster) +75.81%
#3 Cortex Cortex +31.86%
#4 DexNet DexNet +23.19%
#5 OpenEden OpenEden +19.35%
#6 Akedo Akedo +18.27%
#7 MarsCoin MarsCoin +17.92%
#8 Magma Finance Magma Finance +17.81%
#9 Pons Pons +14.45%
#10 MANTRA MANTRA +14.20%
Coin of the day
MowCat MowCat
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
Porton Pharma Solutions Ltd. Porton Pharma Solutions Ltd.

Porton Pharma Solutions Ltd.

300363
Classificação em ações #7517
Porton Pharma Solutions Ltd. caters to pharmaceutical companies by... Porton Pharma Solutions Ltd. caters to pharmaceutical companies by manufacturing and supplying a diverse portfolio of products, which encompasses small molecule active pharmaceutical ingredients (APIs), drug intermediates, various dosage forms, and biologics. The company was formerly known as Porton Fine Chemicals Ltd. until it adopted its current name in January 2018. Established in 2005, Porton Pharma Solutions Ltd. operates from its headquarters in Chongqing, China.
Preço da ação
$2.86
Valor de mercado
$1.56B
Variação (1 dia)
-2.23%
Variação (1 ano)
-11.67%
País
CN
Negociar Porton Pharma Solutions Ltd. (300363)

Categoria

Healthcare
Histórico de rendimento de dividendos para Porton Pharma Solutions Ltd. (300363)
O rendimento de dividendos (TTM) da Porton Pharma Solutions Ltd. (símbolo da ação: 300363) em 2026 é: 0
Rendimento médio dos dividendos nos últimos 5 anos: 0.00%
Histórico de rendimento de dividendos para Porton Pharma Solutions Ltd. (300363) de 2026 a 2026
Rendimento de dividendos no final de cada ano (TTM)
Ano Rendimento de Dividendos Alterar
Não há dados suficientes para as datas fornecidas.
Rendimentos de dividendos (TTM) para empresas semelhantes ou concorrentes
Empresa Rendimento de Dividendos País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.12%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH